These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 37662880)

  • 1. Self-administration of Recombinant Human Growth Hormone with an Electronic Device: Clinical, Economic and Management Benefits of Objective Adherence Monitoring.
    Saz-Parkinson Z; Granados Alonso MDS; Bouza C; Poveda Andrés JL; Amate JM
    J Health Econ Outcomes Res; 2014; 1(3):296-307. PubMed ID: 37662880
    [No Abstract]   [Full Text] [Related]  

  • 2. Adherence to treatment in children with growth hormone deficiency, small for gestational age and Turner syndrome in Mexico: results of the Easypod™ connect observational study (ECOS).
    Blanco-López A; Antillón-Ferreira C; Saavedra-Castillo E; Barrientos-Pérez M; Rivero-Escalante H; Flores-Caloca O; Calzada-León R; Rosas-Guerra CC; Koledova E; Chiquete E; Ayala-Estrada A
    J Endocrinol Invest; 2020 Oct; 43(10):1447-1452. PubMed ID: 32239476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment adherence with the easypod™ growth hormone electronic auto-injector and patient acceptance: survey results from 824 children and their parents.
    Bozzola M; Colle M; Halldin-Stenlid M; Larroque S; Zignani M;
    BMC Endocr Disord; 2011 Feb; 11():4. PubMed ID: 21294891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigating the Impact of the TUITEK
    Su PH; Malik S; Jheeta A; Lin YF; Su SH; Koledova E; Graham S
    Front Endocrinol (Lausanne); 2022; 13():897956. PubMed ID: 35600589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement of treatment adherence with growth hormone by easypod™ device: experience of an Italian centre.
    Maggio MC; Vergara B; Porcelli P; Corsello G
    Ital J Pediatr; 2018 Sep; 44(1):113. PubMed ID: 30261918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating the TUITEK
    Assefi AR; Graham S; Crespo ML; Debicki M; Reston J; Gonzalez J; Jheeta A; Koledova E
    Front Endocrinol (Lausanne); 2023; 14():1129385. PubMed ID: 37091843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-consequence analysis for human recombinant growth hormone (r-hGH) treatment administered via different devices in children with growth hormone deficiency in Italy.
    Foo J; Maghnie M; Colao A; Vlachaki I; Colombo G
    Clinicoecon Outcomes Res; 2019; 11():525-537. PubMed ID: 31692496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adherence to r-hGH Therapy in Pediatric Growth Hormone Deficiency: Current Perspectives on How Patient-Generated Data Will Transform r-hGH Treatment Towards Integrated Care.
    Savage MO; Fernandez-Luque L; Graham S; van Dommelen P; Araujo M; de Arriba A; Koledova E
    Patient Prefer Adherence; 2022; 16():1663-1671. PubMed ID: 35846871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positive Impact of Targeted Educational Intervention in Children With Low Adherence to Growth Hormone Treatment Identified by Use of the Easypod™ Electronic Auto-injector Device.
    Assefi AR; Roca F; Rubstein A; Chareca C
    Front Med Technol; 2021; 3():609878. PubMed ID: 35047902
    [No Abstract]   [Full Text] [Related]  

  • 10. Understanding and meeting the needs of those using growth hormone injection devices.
    Dumas H; Panayiotopoulos P; Parker D; Pongpairochana V
    BMC Endocr Disord; 2006 Oct; 6():5. PubMed ID: 17034628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Observations of nonadherence to recombinant human growth hormone therapy in clinical practice.
    Haverkamp F; Johansson L; Dumas H; Langham S; Tauber M; Veimo D; Chiarelli F
    Clin Ther; 2008 Feb; 30(2):307-16. PubMed ID: 18343269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of machine learning to identify patients at risk of sub-optimal adherence: study based on real-world data from 10,929 children using a connected auto-injector device.
    Spataru A; van Dommelen P; Arnaud L; Le Masne Q; Quarteroni S; Koledova E
    BMC Med Inform Decis Mak; 2022 Jul; 22(1):179. PubMed ID: 35794586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new pen device for injection of recombinant human growth hormone: a convenience, functionality and usability evaluation study.
    Sauer M; Abbotts C
    Patient Prefer Adherence; 2018; 12():27-34. PubMed ID: 29343946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adherence in children with growth hormone deficiency treated with r-hGH and the easypod™ device.
    Loche S; Salerno M; Garofalo P; Cardinale GM; Licenziati MR; Citro G; Caruso Nicoletti M; Cappa M; Longobardi S; Maghnie M; Perrone R
    J Endocrinol Invest; 2016 Dec; 39(12):1419-1424. PubMed ID: 27406716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of real-world data on growth hormone therapy adherence using a connected injection device.
    Koledova E; Tornincasa V; van Dommelen P
    BMC Med Inform Decis Mak; 2020 Jul; 20(1):176. PubMed ID: 32727461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Data-Driven Intervention Framework for Improving Adherence to Growth Hormone Therapy Based on Clustering Analysis and Traffic Light Alerting Systems.
    Araújo M; van Dommelen P; Srivastava J; Koledova E
    Stud Health Technol Inform; 2021 Nov; 287():23-27. PubMed ID: 34795072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Augmented Reality Mobile App (Easypod AR) as a Complementary Tool in the Nurse-Led Integrated Support of Patients Receiving Recombinant Human Growth Hormone: Usability and Validation Study.
    Baños RM; Peltonen LM; Martin B; Koledova E
    JMIR Nurs; 2023 Apr; 6():e44355. PubMed ID: 37083627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of recombinant human growth hormone administered by cool.click 2, a new needle-free device, compared with subcutaneous administration using a conventional syringe and needle.
    Brearley C; Priestley A; Leighton-Scott J; Christen M
    BMC Clin Pharmacol; 2007 Oct; 7():10. PubMed ID: 17922895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Participatory Study to Explore Healthcare Professionals' Perceptions of a Connected Digital Solution for Adherence Monitoring of Recombinant Human Growth Hormone Treatment: Study Protocol and First Findings.
    Rivera-Romero O; Felicia Faienza M; Vergani E; Zucchiatti C; Koledova E
    Stud Health Technol Inform; 2023 May; 302():23-27. PubMed ID: 37203602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.